Results 131 to 140 of about 21,275,692 (207)

Genomic instability, postoperative recurrence and therapeutic vulnerabilities in resectable non‑small cell lung cancer (Review). [PDF]

Oncol Rep
Wang L, Feng Y, Liu Q.
europepmc   +1 more source

[RNAi and non-small cell lung cancer.].

Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2008
Chunyu YANG, Li CAI
openaire   +2 more sources

Refining the clinical interpretation of GLUT1 in non-small cell lung cancer. [PDF]

Transl Lung Cancer Res
Hu M, Wu C.
europepmc   +1 more source

Clinicopathological correlations of perineural invasion in resected non-small cell lung cancer. [PDF]

Front Cell Dev Biol
Sejda A, Sigorski D, Nowakowski JJ, Iżycka-Świeszewska E.   +3 more
europepmc   +1 more source

Guideline concordance of stage IIIA non-small-cell lung cancer treatment in the Australian setting. [PDF]

Intern Med J
Ross G, Conron M, Wright G, Denton E.
europepmc   +1 more source

Landscape of Cell States and Multicellular Ecotypes in Non-Small Cell Lung Cancer. [PDF]

Int J Mol Sci
Li H, Jiang Y, Huo Z, Li S, Luo X, Xie Y, Xi Q, Wang S, Yang L.   +8 more
europepmc   +1 more source

PCK2 Inhibition Reverses Cisplatin Resistance of Non-Small Cell Lung Cancer by Triggering Ferroptosis. [PDF]

FASEB J
Liu J, Wang Z, Gu C, Chen Y, Yang Y, Zhu J, Zhang Y, Shao Y, Pang X, Ge Y, Qian H, Huang JA, Liu Z, Zeng Y, Ji C.   +14 more
europepmc   +1 more source

Chemotherapy of non-small cell lung cancer

Annals of Oncology, 1993
openaire   +2 more sources

Mechanisms of LARP7 in regulating the progression of non-small cell lung cancer. [PDF]

J Thorac Dis
He J, Li C, Liu L, Qian X, Li F, Zhang L, Wang C, Qin H, Ding R.   +8 more
europepmc   +1 more source